| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Angelos M. Stergiou is President and CEO at SLS. Angelos M. Stergiou's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $15.6M at current prices.
The SLS filings lean toward selling, a net 31,891 shares.
Angelos M. Stergiou has 16 Form 4 filings on record from December 2017 to June 2026, all as President and CEO at SELLAS Life Sciences Group (SLS), 2017–2026.
The 23 reported transactions were 9 stock awards, 8 option or other derivative awards, 3 other transactions and 3 open-market sales.
Counted by filing, the open-market trades come to no purchases and 3 sales worth about $59K.
The largest open-market sale was 23,277 shares of SLS at an average $1.25 on December 31, 2018, about $29K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2022 | SLS Sellas Life Sciences Group, Inc. | President and CEO | Sell | 6,494 | $2.61 | $16,938.30 | -3.9% | -37.7% | -57.5% | |
| Dec 2, 2021 | SLS Sellas Life Sciences Group, Inc. | President and CEO | Sell | 2,120 | $6.25 | $13,251.91 | -1.7% | -5.0% | -58.6% | |
| Dec 31, 2018 | SLS Sellas Life Sciences Group, Inc. | President and CEO | Sell | 23,277 | $1.25 | $29,189.36 | -5.2% | - | - |